The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Paclitaxel sensitivity of breast cancer cells with constitutively active NF-κB is enhanced by IκBα super-repressor and parthenolide
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dignam, J. D., Lebovitz, R. M., & Roeder, R. G. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.5.1475 · Cited by 11,260
Green, D. R., & Reed, J. C. (1998) · Science · doi:10.1126/science.281.5381.1309 · Cited by 8,965
Thornberry, N. A., & Lazebnik, Y. (1998) · Science · doi:10.1126/science.281.5381.1312 · Cited by 6,887
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death
Beg, A. A., & Baltimore, D. (1996) · Science · doi:10.1126/science.274.5288.782 · Cited by 3,047
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
Liotta, L. A., Steeg, P. S., & Stetler-Stevenson, W. G. (1991) · Cell · doi:10.1016/0092-8674(91)90642-c · Cited by 2,720
Wang, C.-Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V., & Baldwin, A. S. (1998) · Science · doi:10.1126/science.281.5383.1680 · Cited by 2,711
TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
Wang, C.-Y., Mayo, M. W., & Baldwin, A. S. (1996) · Science · doi:10.1126/science.274.5288.784 · Cited by 2,617
Suppression of TNF-α-Induced Apoptosis by NF-κB
Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., & Verma, I. M. (1996) · Science · doi:10.1126/science.274.5288.787 · Cited by 2,581
IAP family proteins---suppressors of apoptosis
Deveraux, Q. L., & Reed, J. C. (1999) · Genes & Development · doi:10.1101/gad.13.3.239 · Cited by 2,551
Control of apoptosis and mitotic spindle checkpoint by survivin
Li, F., Ambrosini, G., Chu, E. Y., Plescia, J., Tognin, S., Marchisio, P. C., & Altieri, D. C. (1998) · Nature · doi:10.1038/25141 · Cited by 1,870
The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β
Yin, M.-J., Yamamoto, Y., & Gaynor, R. B. (1998) · Nature · doi:10.1038/23948 · Cited by 1,590
Apoptosis in cancer therapy: Crossing the threshold
Fisher, D. E. (1994) · Cell · doi:10.1016/0092-8674(94)90518-5 · Cited by 1,315
NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1
Guttridge, D. C., Albanese, C., Reuther, J. Y., Pestell, R. G., & Baldwin, A. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5785 · Cited by 1,312
Pierce, J. W., Schoenleber, R., Jesmok, G., Best, J., Moore, S. A., Collins, T., & Gerritsen, M. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.21096 · Cited by 1,053
Wang, C.-Y., Cusack, J. C., Liu, R., & Baldwin, A. S. (1999) · Nature Medicine · doi:10.1038/7410 · Cited by 988
BAX-induced cell death may not require interleukin 1β-converting enzyme-like proteases
Xiang, J., Chao, D. T., & Korsmeyer, S. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14559 · Cited by 884
Constitutive Activation of NF-κB during Progression of Breast Cancer to Hormone-Independent Growth
Nakshatri, H., Bhat-Nakshatri, P., Martin, D. A., Goulet, R. J., & Sledge, G. W. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.3629 · Cited by 819
Self-citationHinz, M., Krappmann, D., Eichten, A., Heder, A., Scheidereit, C., & Strauss, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2690 · Cited by 788
Bargou, R. C., Emmerich, F., Krappmann, D., Bommert, K., Mapara, M. Y., Arnold, W., Royer, H. D., Grinstein, E., Greiner, A., Scheidereit, C., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119849 · Cited by 761
Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
Sovak, M. A., Bellas, R. E., Kim, D. W., Zanieski, G. J., Rogers, A. E., Traish, A. M., & Sonenshein, G. E. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119848 · Cited by 720
Zong, W.-X., Edelstein, L. C., Chen, C., Bash, J., & Gelinas, C. (1999) · Genes & Development · doi:10.1101/gad.13.4.382 · Cited by 720
(1990) · PubMed · Cited by 612
Wang, C.-Y., Guttridge, D. C., Mayo, M. W., & Baldwin, A. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.5923 · Cited by 590
Manna, S. K., Zhang, H. J., Yan, T., Oberley, L. W., & Aggarwal, B. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.13245 · Cited by 564
Lee, H. H., Dadgostar, H., Cheng, Q., Shu, J., & Cheng, G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9136 · Cited by 521
Lyß, G., Knorre, A., Schmidt, T. J., Pahl, H. L., & Merfort, I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.50.33508 · Cited by 474
Criteria for Analyzing Interactions between Biologically Active Agents
(1981) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60912-4 · Cited by 454
Cogswell, P. C., Guttridge, D. C., Funkhouser, W. K., & Baldwin, A. S. (2000) · Oncogene · doi:10.1038/sj.onc.1203412 · Cited by 452
Gutman, A., & Wasylyk, B. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07394.x · Cited by 449
Grumont, R. J., Rourke, I. J., & Gerondakis, S. (1999) · Genes & Development · doi:10.1101/gad.13.4.400 · Cited by 403
A requirement for NF-kappa B activation in Bcr-Abl-mediated transformation
Reuther, J. Y., Reuther, G. W., Cortez, D., Pendergast, A. M., & Baldwin Jr., A. S. (1998) · Genes & Development · doi:10.1101/gad.12.7.968 · Cited by 392
Yang, F., de Villiers, W. J. S., McClain, C. J., & Varilek, G. W. (1998) · The Journal of Nutrition · doi:10.1093/jn/128.12.2334 · Cited by 389
Blagosklonny, M. V., Schulte, T., Nguyen, P., Trepel, J. B., & Neckers, L. (1996) · PubMed · Cited by 375
Hehner, S. P., Hofmann, T. G., Dröge, W., & Schmitz, M. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.10.5617 · Cited by 355
Hehner, S. P., Heinrich, M., Bork, P. M., Vogt, M., Ratter, F., Lehmann, V., Schulze-Osthoff, K., Dröge, W., & Schmitz, M. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.3.1288 · Cited by 338
Bork, P. M., Schmitz, M. L., Kuhnt, M., Escher, C., & Heinrich, M. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01502-5 · Cited by 327
Bridging the Gap: Composition, Regulation, and Physiological Function of the IκB Kinase Complex
Zandi, E., & Karin, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.4547 · Cited by 321
Giri, D. K., & Aggarwal, B. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.14008 · Cited by 299
Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF- B site
Galien, R., & Garcia, T. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.12.2424 · Cited by 298
Differentiation state and invasiveness of human breast cancer cell lines
Sommers, C. L., Byers, S. W., Thompson, E. W., Torri, J. A., & Gelmann, E. P. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00666165 · Cited by 270
Activation of NF-κB by Antineoplastic Agents
Das, K. C., & White, C. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.23.14914 · Cited by 269
Levkau, B., Herren, B., Koyama, H., Ross, R., & Raines, E. W. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.579 · Cited by 257
Jones, P. L., Ping, D., & Boss, J. M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.12.6970 · Cited by 244
Kumar, A., Dhawan, S., Hardegen, N. J., & Aggarwal, B. B. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00557-1 · Cited by 238
Miyake, H., Nelson, C. C., Rennie, P. S., & Gleave, M. E. (2000) · PubMed · Cited by 223
Phosphorylation of Bcl-2 Is a Marker of M Phase Events and Not a Determinant of Apoptosis
Ling, Y.-H., Tornos, C., & Perez-Soler, R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.18984 · Cited by 222
Legrand, O., Simonin, G., Perrot, J.-Y., Zittoun, R., & Marie, J.-P. (1998) · Blood · doi:10.1182/blood.v91.12.4480 · Cited by 204
Bargou, R. C., Wagener, C., Bommert, K., Mapara, M. Y., Daniel, P. T., Arnold, W., Dietel, M., Guski, H., Feller, A., Royer, H. D., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118715 · Cited by 189
Apoptosis overrides survival signals through a caspase-mediated dominant-negative NF-κB loop
Levkau, B., Scatena, M., Giachelli, C. M., Ross, R., & Raines, E. W. (1999) · Nature Cell Biology · doi:10.1038/12050 · Cited by 188
Accessory protein regulation of microtubule dynamics throughout the cell cycle
Cassimeris, L. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80017-9 · Cited by 184
Taxol induction of p21WAF1 and p53 requires c-raf-1.
Blagosklonny, M. V., Schulte, T. W., Nguyen, P., Mimnaugh, E. G., Trepel, J. B., & Neckers, L. M. (1995) · PubMed · Cited by 182
Kelleher, D. J., & Gilmore, R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.4994 · Cited by 178
Dong, G., Chen, Z., Kato, T., & Waes, C. V. (1999) · PubMed · Cited by 161
Kumar, R., Mandal, M., Lipton, A., Harvey, H. A., & Thompson, C. B. (1996) · PubMed · Cited by 144
Shattuck-Brandt, R. L., & Richmond, A. (1997) · PubMed · Cited by 142
Inhibition of Activator Protein 1 Activity by Berberine in Human Hepatoma Cells
Fukuda, K., Hibiya, Y., Mutoh, M., Koshiji, M., Akao, S., & Fujiwara, H. (1999) · Planta Medica · doi:10.1055/s-2006-960795 · Cited by 112
Bentires‐Alj, M., Hellin, A., Ameyar‐Zazoua, M., Chouaïb, S., Merville, M. P., & Bours, V. (1999) · PubMed · Cited by 94
Bhat‐Nakshatri, P., Newton, T. R., Goulet, R. J., & Nakshatri, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6971 · Cited by 92
Self-citationPanvichian, R., Orth, K., Day, M. L., Day, K. C., Pilat, M. J., & Pienta, K. J. (1998) · PubMed · Cited by 70
Multidrug resistance — a multiplex phenomenon
Baldini, N. (1997) · Nature Medicine · doi:10.1038/nm0497-378 · Cited by 67
Newton, T. R., Patel, N. M., Bhat‐Nakshatri, P., Stauss, C. R., Goulet, R. J., & Nakshatri, H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18827 · Cited by 64
Self-citationCoverage and Quality of Oral Cancer Information in the Popular Press: 1987–98
Canto, M. T., Kawaguchi, Y., & Horowitz, A. M. (1998) · Journal of Public Health Dentistry · doi:10.1111/j.1752-7325.1998.tb03000.x · Cited by 38
Cited by
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
Baldwin, A. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11991 · Cited by 1,434
Nuclear factor-κB inhibitors as sensitizers to anticancer drugs
Nakanishi, C., & Toi, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1588 · Cited by 724
Nanoparticle-based combination therapy toward overcoming drug resistance in cancer
Hu, C.-M. J., & Zhang, L. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.01.008 · Cited by 686
Guzman, M. L., Rossi, R. M., Karnischky, L., Li, X., Peterson, D. R., Howard, D. S., & Jordan, C. T. (2005) · Blood · doi:10.1182/blood-2004-10-4135 · Cited by 678
Development of the Proteasome Inhibitor Velcade™ (Bortezomib)
Adams, J., & Kauffman, M. (2004) · Cancer Investigation · doi:10.1081/cnv-120030218 · Cited by 654
Metadata
- Authors
- Patel, N. M., Nozaki, S., Shortle, N. H., Bhat-Nakshatri, P., Newton, T. R., Rice, S., Gelfanov, V., Boswell, S. H., Goulet, R. J., Sledge, G. W., & Nakshatri, H.
- Venue
- Oncogene
- Published
- 2000-08-24
- Volume
- 19
- Issue
- 36
- Pages
- 4159-4169
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1554632349
- Cited by
- 294
- References
- 63
- FWCI
- 5.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.